Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Dec 20, 2024, 4:00 PM
4.990
+0.040 (0.81%)
After-hours: Dec 20, 2024, 5:47 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $159.37 million as of December 20, 2024. Its market cap has increased by 72.29% in one year.
Market Cap
159.37M
Enterprise Value
-10.47M
1-Year Change
72.29%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $159.37M, a decrease of -55.08%. That is a compound annual growth rate of -42.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 159.37M | 28.42% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| scPharmaceuticals | 165.63M |
| TScan Therapeutics | 165.56M |
| Greenwich LifeSciences | 164.57M |
| Checkpoint Therapeutics | 164.57M |
| Caribou Biosciences | 163.90M |
| Cellectis | 163.20M |
| Nanobiotix | 162.51M |
| Corbus Pharmaceuticals Holdings | 162.35M |